Periostin‐ IHH feedforward loop promotes hepatocellular carcinoma development by enhancing hepatic fibrosis and tumor cell proliferation
The Journal of Pathology · 2025
DOI: 10.1002/path.6467 ↗At a glance
Journal article in The Journal of Pathology, 2025. Written by Bin Liu and 7 co-authors. Institution: The First Affiliated Hospital, State Key Laboratory of Cellular Stress Biology, School of Medicine, Xiamen University, Xiamen, PR China. Major MEDLINE topics: Liver Cirrhosis, Periostin, Carcinoma, Hepatocellular, Hedgehog Proteins. 35 references. Funded by: Natural Science Foundation of Fujian Province, the Scientific Research Foundation of State Key Laboratory of Vaccines for Infectious Diseasea, Xiang An Biomedicine Laboratory, National Natural Science Foundation of China.
Abstract (original language)
The extracellular matrix protein periostin plays a critical role in the progression of hepatic fibrosis and hepatocellular carcinoma (HCC). However, little is known about how periostin regulates both hepatic fibrosis and tumor growth in the progression of HCC. Here we demonstrate that periostin deficiency impairs HCC development and decreases tissue stiffness of liver tumors in DEN/CCl 4 ‐treated mice. Increased matrix stiffness enhanced periostin expression in hepatic stellate cells (HSCs). The combination of periostin and increased stiffness synergistically promoted HCC cell proliferation in vitro . Moreover, periostin deficiency in HSCs impaired both HSC‐promoted and stiffness‐increased HCC cell proliferation in vivo . We further demonstrated that periostin promotes Indian hedgehog (IHH) expression in HCC cells through the integrin‐PYK2‐TAZ pathway. Conversely, IHH increased the expression of periostin in HSCs via GLI2. Periostin expression positively correlates with fibrotic features and IHH signaling in clinical HCC tissues. Collectively, these findings indicate that periostin and IHH cooperatively contribute to the development of HCC by regulating the tumor–stroma crosstalk via the periostin‐integrin‐PYK2‐TAZ‐IHH pathway in tumor cells and IHH‐GLI2‐periostin signaling in HSCs. © 2025 The Pathological Society of Great Britain and Ireland.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- The First Affiliated Hospital, State Key Laboratory of Cellular Stress Biology, School of Medicine, Xiamen University, Xiamen, PR China.
- State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Xiamen University, Xiamen, PR China.
- Key Laboratory of Natural Microbial Medicine Research of Jiangxi Province, Jiangxi Science and Technology Normal University, Nanchang, PR China.
ORCID profiles: Gaoliang Ouyang, Tiantian Wu
Funding
- Natural Science Foundation of Fujian Province
- the Scientific Research Foundation of State Key Laboratory of Vaccines for Infectious Diseasea, Xiang An Biomedicine Laboratory
- National Natural Science Foundation of China
Cite
APA
Liu, B., Li, X., Zhang, M., Liu, X., Sun, J., Deng, M., Ouyang, G., & Wu, T. (2025). Periostin‐ IHH feedforward loop promotes hepatocellular carcinoma development by enhancing hepatic fibrosis and tumor cell proliferation. The Journal of Pathology. https://doi.org/10.1002/path.6467
Vancouver
Liu B, Li X, Zhang M, Liu X, Sun J, Deng M, et al. Periostin‐ IHH feedforward loop promotes hepatocellular carcinoma development by enhancing hepatic fibrosis and tumor cell proliferation. The Journal of Pathology. 2025. doi:10.1002/path.6467
BibTeX
@article{Liu2025,
author = {Liu, Bin and Li, Xuebin and Zhang, Menghao and Liu, Xingxing and Sun, Junxing and Deng, Mingjiao and Ouyang, Gaoliang and Wu, Tiantian},
title = {Periostin‐ IHH feedforward loop promotes hepatocellular carcinoma development by enhancing hepatic fibrosis and tumor cell proliferation},
journal = {The Journal of Pathology},
year = {2025},
doi = {10.1002/path.6467}
}
EUVIMED